Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Gsur

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
World Journal of Urology|December 3, 2003
Genetic polymorphisms and prostate cancer riskAndrea Gsur, Elisabeth Feik, Stephan Madersbacher
Biology|August 27, 2021
Colorectal Cancer Study of Austria (CORSA): A Population-Based Multicenter StudyAndrea Gsur, Andreas Baierl, Stefanie Brezina
The International Journal of Biochemistry & Cell Biology|May 11, 2015
The increased Sprouty4 expression in response to serum is transcriptionally controlled by Specific protein 1Angelina Doriguzzi, Barbara Haigl, Andrea Gsur, et al.
Mutagenesis|April 8, 2020
Genome-wide association study of germline copy number variations reveals an association with prostate cancer aggressivenessStefanie Brezina, Moritz Feigl, Tanja Gumpenberger, et al.
Ebiomedicine|October 2, 2015
Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPDMatthias Wielscher, Klemens Vierlinger, Ulrike Kegler, et al.
Microarrays (Basel, Switzerland)|September 8, 2016
Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization StrategiesStefanie Brezina, Regina Soldo, Roman Kreuzhuber, et al.
Cell Biochemistry and Function|April 26, 2013
In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffectedRosana Maria Kral, Christoph-Erik Mayer, Vanita Vanas, et al.
International Journal of Oncology|January 24, 2014
Expression of microRNA-21 in non-small cell lung cancer tissue increases with disease progression and is likely caused by growth conditional changes during malignant transformationBarbara Haigl, Vanita Vanas, Ulrike Setinek, et al.
FEBS Letters|July 9, 2013
Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cellsNadine Rathmanner, Barbara Haigl, Vanita Vanas, et al.
The Prostate|March 29, 2002
Vitamin D receptor gene polymorphism and prostate cancer riskAndrea Gsur, Stephan Madersbacher, Gerald Haidinger, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
World Journal of Urology|December 3, 2003
Genetic polymorphisms and prostate cancer riskAndrea Gsur, Elisabeth Feik, Stephan Madersbacher
Biology|August 27, 2021
Colorectal Cancer Study of Austria (CORSA): A Population-Based Multicenter StudyAndrea Gsur, Andreas Baierl, Stefanie Brezina
The International Journal of Biochemistry & Cell Biology|May 11, 2015
The increased Sprouty4 expression in response to serum is transcriptionally controlled by Specific protein 1Angelina Doriguzzi, Barbara Haigl, Andrea Gsur, et al.
Mutagenesis|April 8, 2020
Genome-wide association study of germline copy number variations reveals an association with prostate cancer aggressivenessStefanie Brezina, Moritz Feigl, Tanja Gumpenberger, et al.
Ebiomedicine|October 2, 2015
Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPDMatthias Wielscher, Klemens Vierlinger, Ulrike Kegler, et al.
Microarrays (Basel, Switzerland)|September 8, 2016
Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization StrategiesStefanie Brezina, Regina Soldo, Roman Kreuzhuber, et al.
Cell Biochemistry and Function|April 26, 2013
In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffectedRosana Maria Kral, Christoph-Erik Mayer, Vanita Vanas, et al.
International Journal of Oncology|January 24, 2014
Expression of microRNA-21 in non-small cell lung cancer tissue increases with disease progression and is likely caused by growth conditional changes during malignant transformationBarbara Haigl, Vanita Vanas, Ulrike Setinek, et al.
FEBS Letters|July 9, 2013
Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cellsNadine Rathmanner, Barbara Haigl, Vanita Vanas, et al.
The Prostate|March 29, 2002
Vitamin D receptor gene polymorphism and prostate cancer riskAndrea Gsur, Stephan Madersbacher, Gerald Haidinger, et al.
Pageof 12